Hantz Financial Services, Inc. Kaleido Biosciences, Inc. Transaction History

Hantz Financial Services, Inc.

  • $5.63 Billion
  • Q3 2024

A detailed history of Hantz Financial Services, Inc. transactions in Kaleido Biosciences, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 350 shares of KLDO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350
Holding current value
$0
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.0 - $0.0 $0 - $0
350 New
350 $0
Q1 2024

Aug 06, 2024
BUY
$0.0 - $0.0 $0 - $0
350 New
350 $0

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email